TuHURA Biosciences, Inc.
HURA · NASDAQ
9/30/2025 | 6/30/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $18 | $0 |
| Gross Profit | $0 | $0 | -$18 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $14,477 | $4,927 | $3,976 | $252 |
| G&A Expenses | $0 | $4,949 | $0 | $1,957 |
| SG&A Expenses | $9,145 | $4,949 | $1,701 | $1,957 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$185 | $0 | $0 | $0 |
| Operating Expenses | $23,623 | $9,876 | $5,677 | $2,209 |
| Operating Income | $0 | -$9,876 | -$5,695 | -$2,209 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $332 | $352 | -$301 | $48 |
| Pre-Tax Income | $0 | -$9,524 | -$5,996 | -$2,161 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23,297 | -$9,524 | -$5,996 | -$6 |
| % Margin | – | – | – | – |
| EPS | 0 | -0.214 | -0.142 | -3 |
| % Growth | 100% | -50.9% | 95.3% | – |
| EPS Diluted | 0 | -0.214 | -0.142 | -3 |
| Weighted Avg Shares Out | 0 | 44,555 | 42,324 | 2,182 |
| Weighted Avg Shares Out Dil | 0 | 44,555 | 42,324 | 2,182 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $29 | $164 | $49 |
| Interest Expense | $17 | $0 | $523 | $0 |
| Depreciation & Amortization | $0 | $0 | $18 | $29 |
| EBITDA | $0 | -$9,524 | -$5,455 | -$2,180 |
| % Margin | – | – | – | – |